Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$21.87 - $25.59 $1.73 Million - $2.02 Million
-79,076 Reduced 8.3%
874,050 $22.3 Million
Q1 2024

May 14, 2024

BUY
$21.81 - $25.14 $6.8 Million - $7.83 Million
311,622 Added 48.58%
953,126 $22.4 Million
Q4 2023

Feb 13, 2024

BUY
$14.29 - $25.95 $9.17 Million - $16.6 Million
641,504 New
641,504 $16.1 Million
Q4 2021

Feb 01, 2022

SELL
$18.0 - $34.82 $197,982 - $382,985
-10,999 Closed
0 $0
Q3 2021

Nov 12, 2021

BUY
$23.42 - $37.93 $257,596 - $417,192
10,999 New
10,999 $267,000

Others Institutions Holding OLK

About Olink Holding AB (publ)


  • Ticker OLK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 119,098,000
  • Description
  • Olink Holding AB (publ) provides various products and services for the academic, government, biopharmaceutical, biotechnology, and other institutions that focuses on life science research. Its products include Olink Explore for cardiovascular and metabolic, oncology, neurology, or inflammation diseases; Olink Target product line; and Olink Focus...
More about OLK
Track This Portfolio

Track Qube Research & Technologies LTD Portfolio

Follow Qube Research & Technologies LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

News

Stay updated on Qube Research & Technologies LTD with notifications on news.